Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October-2024 Volume 28 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2024 Volume 28 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells

  • Authors:
    • Xuexia Geng
    • Jun Yuan
    • Wenjie Xu
    • Deng Zou
    • Yuxuan Sun
    • Jun Li
  • View Affiliations / Copyright

    Affiliations: School of Life Science, Huaibei Normal University, Huaibei, Anhui 235000, P.R. China
    Copyright: © Geng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 469
    |
    Published online on: July 31, 2024
       https://doi.org/10.3892/ol.2024.14602
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Highly metastatic and heterogeneous breast cancer affects the health of women worldwide. Abnormal expression of tyrosine 3‑monooxygenase/tryptophan 5‑monooxygenase activation protein β (YWHAB), also known as 14‑3‑3β, is associated with the tumorigenesis and progression of bladder cancer, lung cancer and hepatocellular carcinoma; however, to the best of our knowledge, the role of YWHAB in breast cancer remains unknown. In the present study, a dual luciferase assay demonstrated that the transcription factor iroquois homeobox 5 may regulate YWHAB expression by affecting the promoter sequence upstream of its transcription start site. Subsequently, it was demonstrated that overexpression of YWHAB did not affect proliferation, but did reduce the migration and invasion of MDA‑MB‑231 cells. Furthermore, knockdown of YWHAB promoted the migration and invasion of MCF7 cells. Transcriptomics analysis demonstrated that when YWHAB was overexpressed, 61 genes were differentially expressed, of which 43 genes were upregulated and 18 genes were downregulated. These differentially expressed genes (DEGs) were enriched in cancer‑related pathways, such as ‘TNF signaling pathway’ [Kyoto Encyclopedia of Genes and Genomes (KEGG): map04688]. The pathway with the largest number of DEGs was ‘Rheumatoid arthritis’ (KEGG: map05323). Notably, YWHAB downregulated vimentin, which is a mesenchymal marker, thus suggesting that it may weaken the mesenchymal properties of cells. These findings indicate that YWHAB may be a potential therapeutic target in breast cancer and further work should be performed to assess its actions as a potential tumor suppressor.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022. View Article : Google Scholar : PubMed/NCBI

2 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Wang L, Zhang S and Wang X: The metabolic mechanisms of breast cancer metastasis. Front Oncol. 10:6024162020. View Article : Google Scholar : PubMed/NCBI

4 

Gui P: Evolution of metastasis: New tools and insights. Trends Cancer. 8:98–109. 2022. View Article : Google Scholar : PubMed/NCBI

5 

Mehlen P and Puisieux A: Metastasis: A question of life or death. Nat Rev Cancer. 6:449–458. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F and Wu G: Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 71:1292–1301. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Yan M, Wang J, Ren Y, Li L, He W, Zhang Y, Liu T and Li Z: Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death Dis. 10:2042019. View Article : Google Scholar : PubMed/NCBI

9 

Zhang J, Deng H and Wang J: LTBP1 promotes the progression of triple negative breast cancer via activating the RhoA/ROCK signaling pathway. Cancer Insight. 3:1–3. 2023. View Article : Google Scholar

10 

Blazeck J and Alper HS: Promoter engineering: Recent advances in controlling transcription at the most fundamental level. Biotechnol. 8:46–58. 2013.

11 

Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H and Liddington RC: 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem. 273:16305–16310. 1998. View Article : Google Scholar : PubMed/NCBI

12 

Aghazadeh Y and Papadopoulos V: The role of the 14-3-3 protein family in health, disease, and drug development. Drug Discov Today. 21:278–287. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Gardino AK and Yaffe MB: 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol. 22:688–695. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Sime W, Niu Q, Abassi Y, Masoumi KC, Zarrizi R, Køhler JB and Massoumi R: BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. Cell Death Dis. 9:4582018. View Article : Google Scholar : PubMed/NCBI

15 

Ou TT, Wang CJ, Lee YS, Wu CH and Lee HJ: Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells. Mol Nutr Food Res. 54:1781–1790. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Komiya Y, Akiyama H, Sakumoto R and Tashiro F: FBI1/Akirin2 promotes tumorigenicity and metastasis of Lewis lung carcinoma cells. Biochem Biophys Res Commun. 444:382–386. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Cao L, Lei H, Chang MZ, Liu ZQ and Bie XH: Down-regulation of 14-3-3β exerts anti-cancer effects through inducing ER stress in human glioma U87 cells: Involvement of CHOP-Wnt pathway. Biochem Biophys Res Commun. 462:389–395. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Gong F, Wang G, Ye J, Li T, Bai H and Wang WW: 14-3-3beta regulates the proliferation of glioma cells through the GSK3beta/beta-catenin signaling pathway. Oncol Rep. 30:2976–2982. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Hu X, Bao M, Huang J, Zhou L and Zheng S: Identification and validation of novel biomarkers for diagnosis and prognosis of hepatocellular carcinoma. Front Oncol. 10:5414792020. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Smith T, Heger A and Sudbery L: UMI-tools: Modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27:491–499. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Kim D, Langmead B and Salzberg SL: HISAT: A fast spliced aligner with low memory requirements. Nat Methods. 12:357–360. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT and Salzberg SL: StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 33:290–295. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Liao Y, Smyth GK and Shi W: featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 30:923–930. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Love MI, Huber W and Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI

26 

Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Zhu YH, Tao ZH, Chen Y, Lin SC, Zhu MG, Ji W, Liu XJ, Li T and Hu X: Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT. Breast Cancer Res Treat. 193:65–81. 2022. View Article : Google Scholar : PubMed/NCBI

28 

Wang K, Zheng J, Yu J, Wu Y, Guo J, Xu Z and Sun X: Knockdown of MMP1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/cmyc signaling pathway and EMT. Oncol Rep. 43:1103–1112. 2020.PubMed/NCBI

29 

Feng KN, Meng P, Zou XL, Zhang M, Li H, Yang HL, Li HT and Zhang TT: IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma. Resp Res. 23:2442022. View Article : Google Scholar

30 

Nelson CM, Khauv D, Bissell MJ and Radisky DC: Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J Cell Biochem. 105:25–33. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Chu C, Liu X, Bai X, Zhao T, Wang M, Xu RC, Li MQ, Hu YY, Li WH, Liu H, et al: MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3. Int J Biol Sci. 14:228–236. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Correia AL, Mori H, Chen EI, Schmitt FC and Bissell MJ: The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90beta. Genes Dev. 27:805–817. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Gómez-Skarmeta JL and Modolell J: Iroquois genes: Genomic organization and function in vertebrate neural development. Curr Opin Genet Dev. 12:403–408. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Kim KH, Rosen A, Bruneau BG, Hui CC and Backx PH: Iroquois homeodomain transcription factors in heart development and function. Circ Res. 110:1513–1524. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Leyns L, Gómez-Skarmeta JL and Dambly-Chaudière C: iroquois: A prepattern gene that controls the formation of bristles on the thorax of Drosophila. Mech Develop. 59:63–72. 1996. View Article : Google Scholar : PubMed/NCBI

37 

Marcinkiewicz KM and Gudas LJ: Altered epigenetic regulation of homeobox genes in human oral squamous cell carcinoma cells. Exp Cell Res. 320:128–143. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Huang L, Song F, Sun H, Zhang L and Huang C: IRX5 promotes NF-κB signalling to increase proliferation, migration and invasion via OPN in tongue squamous cell carcinoma. J Cell Mol Med. 22:3899–3910. 2018. View Article : Google Scholar : PubMed/NCBI

39 

Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, QianD Z and Beer TM: The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin Cancer Res. 14:3562–3570. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Zhu L, Dai L, Yang N, Liu M, Ma S, Li CC, Shen J, Lin T, Wang D, Pan W and Li X: Transcription factor IRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway. Cell Biochem Funct. 38:621–629. 2020. View Article : Google Scholar : PubMed/NCBI

41 

Zhu Q, Wu Y, Yang M, Wang Z, Zhang H, Jiang XL, Chen M, Jin TY and Wang T: IRX5 promotes colorectal cancer metastasis by negatively regulating the core components of the RHOA pathway. Mol Carcinog. 58:2065–2076. 2019. View Article : Google Scholar : PubMed/NCBI

42 

Hua Y, Wang H, Wang H, Wu X, Yang L, Wang CL, Li X, Jin YH, Li M, Wang L, et al: Circular RNA Circ_0006282 promotes cell proliferation and metastasis in gastric cancer by regulating MicroRNA-144-5p/Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase activation protein β axis. Cancer Manag Res. 13:815–827. 2021. View Article : Google Scholar : PubMed/NCBI

43 

Li C, Li Z and Zhang M: Low Expression of 14-3-3beta is associated with adverse survival of diffuse large B-Cell lymphoma patients. Front Med (Lausanne). 6:2372019. View Article : Google Scholar : PubMed/NCBI

44 

Wu YJ, Jan YJ, Ko BS, Liang SM and Liou JY: Involvement of 14-3-3 proteins in regulating tumor progression of hepatocellular carcinoma. Cancers. 7:1022–1036. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Liu TA, Jan YJ, Ko BS, Chen SC, Liang SM, Hung YL, Chiun H, Shen TL, Lee YM, Chen PF, et al: Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am J Pathol. 179:2698–2708. 2011. View Article : Google Scholar : PubMed/NCBI

46 

Tang Y, Lv P, Sun Z, Han L and Zhou W: 14-3-3β promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3K/Akt/NF-κB pathway. PLoS One. 11:e01460702016. View Article : Google Scholar : PubMed/NCBI

47 

Zhang X, Zhang Q, Zhang K, Wang F, Qiao X and Cui JQ: Circ SMARCA5 inhibited tumor metastasis by interacting with SND1 and downregulating the YWHAB gene in cervical cancer. Cell Transplant. 30:9636897209837862021. View Article : Google Scholar : PubMed/NCBI

48 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

49 

Driskell RR, Lichtenberger BM, Hoste E, Kretzschmar K, Simons BD, Charalambous M, Ferron SR, Herault Y, Pavlovic G, Ferguson-Smith AC and Watt FM: Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature. 504:277–281. 2013. View Article : Google Scholar : PubMed/NCBI

50 

Lohneis P, Sinn M, Klein F, Bischoff S, Striefler JK, Wislocka L, Sinn BV, Pelzer U, Oettle H, Riess H, et al: Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. Br J Cancer. 118:1485–1491. 2018. View Article : Google Scholar : PubMed/NCBI

51 

Calaf GM, Balajee AS, Montalvo-Villagra MT, Leon M, Navarrete M D, Alvarez RG, Roy D, Narayan G and Jorge AQ: Vimentin and Notch as biomarkers for breast cancer progression. Oncol Lett. 7:721–727. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Geng X, Yuan J, Xu W, Zou D, Sun Y and Li J: YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. Oncol Lett 28: 469, 2024.
APA
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., & Li, J. (2024). YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. Oncology Letters, 28, 469. https://doi.org/10.3892/ol.2024.14602
MLA
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., Li, J."YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells". Oncology Letters 28.4 (2024): 469.
Chicago
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., Li, J."YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells". Oncology Letters 28, no. 4 (2024): 469. https://doi.org/10.3892/ol.2024.14602
Copy and paste a formatted citation
x
Spandidos Publications style
Geng X, Yuan J, Xu W, Zou D, Sun Y and Li J: YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. Oncol Lett 28: 469, 2024.
APA
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., & Li, J. (2024). YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. Oncology Letters, 28, 469. https://doi.org/10.3892/ol.2024.14602
MLA
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., Li, J."YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells". Oncology Letters 28.4 (2024): 469.
Chicago
Geng, X., Yuan, J., Xu, W., Zou, D., Sun, Y., Li, J."YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells". Oncology Letters 28, no. 4 (2024): 469. https://doi.org/10.3892/ol.2024.14602
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team